BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fan K, Zhang D, Li M, Shen S, Wang J, Ni X, Gong Z, Zheng B, Gao Z, Ni X, Suo T, Liu H, Liu H. Carboxyl-terminal polypeptide fragment of MUC16 combing stathmin1 promotes gallbladder cancer cell migration and invasion. Med Oncol 2020;37:114. [PMID: 33196934 DOI: 10.1007/s12032-020-01438-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Ferrer VP. MUC16 mutation is associated with tumor grade, clinical features, and prognosis in glioma patients. Cancer Genetics 2022. [DOI: 10.1016/j.cancergen.2022.11.003] [Reference Citation Analysis]
2 Ferrer VP. MUC16 mutation is associated with tumor grade, clinical features, and prognosis in glioma patients.. [DOI: 10.1101/2022.02.10.22270821] [Reference Citation Analysis]
3 Nie L, Zhang C, Song H, Zhao Q, Cheng L, Zhang P, Yang X, Malaguarnera M. Overexpression of Stathmin 1 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration in Ovarian Cancer. Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/3554100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zheng B, Wang J, Fan K, Sun W, Wan W, Gao Z, Ni X, Zhang D, Ni X, Suo T, Liu H, Liu H, Shen S. lncRNA RP11-147L13.8 suppresses metastasis and chemo-resistance by modulating the phosphorylation of c-Jun protein in GBC. Mol Ther Oncolytics 2021;23:124-37. [PMID: 34703881 DOI: 10.1016/j.omto.2021.08.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]